Related Experiment Video
Updated: Jul 9, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
[Meconium-stained amniotic fluid and intra-amniotic infection]
Pi-Xiang Pi1, Fu-Fan Zhu, Jian Huang
1Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|April 5, 2005
Summary
Meconium-stained amniotic fluid indicates fetal distress but does not correlate with intra-amniotic infection. This finding is crucial for understanding pregnancy complications and neonatal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Health
- Perinatal Medicine
Context:
- Meconium-stained amniotic fluid (MSAF) is a common intrapartum event.
- The association between MSAF and intra-amniotic infection (IAI) remains debated.
- Understanding these relationships is vital for perinatal care.
Purpose:
- To investigate the correlation between meconium-stained amniotic fluid and intra-amniotic infection.
- To assess the relationship between MSAF severity and inflammatory markers.
- To evaluate neonatal outcomes and puerperal infection rates in relation to MSAF.
Summary:
- A study involving 56 cesarean section patients examined MSAF and IAI.
- Interleukin-6 levels and placental inflammatory cell infiltration were measured.
- Results showed MSAF is linked to fetal distress but not IAI.
Impact:
- MSAF serves as an indicator of fetal distress.
- This research clarifies that MSAF is not a direct marker for intra-amniotic infection.
- Findings can inform clinical management and risk assessment during labor.
More Related Videos
Related Concept Videos
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...